Roya Zoraghi

1.7k total citations
31 papers, 1.2k citations indexed

About

Roya Zoraghi is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Roya Zoraghi has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 16 papers in Pharmacology and 15 papers in Organic Chemistry. Recurrent topics in Roya Zoraghi's work include Phosphodiesterase function and regulation (20 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Chemical synthesis and alkaloids (9 papers). Roya Zoraghi is often cited by papers focused on Phosphodiesterase function and regulation (20 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Chemical synthesis and alkaloids (9 papers). Roya Zoraghi collaborates with scholars based in United States, Canada and Switzerland. Roya Zoraghi's co-authors include Sharron H. Francis, Jackie D. Corbin, Emmanuel P. Bessay, Thomas Seebeck, Neil E. Reiner, Alfreda Beasley, Mitsi A. Blount, Konjeti R. Sekhar, Hengming Ke and Stefan Kunz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Roya Zoraghi

31 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roya Zoraghi United States	20	849	339	298	150	146	31	1.2k
Lian Xun Piao China	28	860 1.0×	173 0.5×	130 0.4×	24 0.2×	319 2.2×	58	1.9k
David Brown United States	25	443 0.5×	786 2.3×	803 2.7×	32 0.2×	278 1.9×	34	2.0k
Thomas H. Hudson United States	20	466 0.5×	138 0.4×	200 0.7×	19 0.1×	70 0.5×	23	1.1k
Khalid Z. Matalka Jordan	20	233 0.3×	104 0.3×	98 0.3×	34 0.2×	57 0.4×	55	1.1k
Judith V. Hobrath United States	20	608 0.7×	143 0.4×	226 0.8×	30 0.2×	211 1.4×	34	1.3k
Kazuo Tsuzuki Japan	20	337 0.4×	173 0.5×	259 0.9×	12 0.1×	295 2.0×	44	1.1k
R. Woestenborghs Belgium	18	338 0.4×	170 0.5×	66 0.2×	159 1.1×	562 3.8×	26	1.7k
Ray Chang United States	11	375 0.4×	172 0.5×	110 0.4×	15 0.1×	84 0.6×	13	811
Athar Alam India	17	448 0.5×	87 0.3×	94 0.3×	21 0.1×	85 0.6×	29	1.2k
Eun‐Mi Kim South Korea	14	427 0.5×	111 0.3×	88 0.3×	25 0.2×	69 0.5×	39	743

Countries citing papers authored by Roya Zoraghi

Since Specialization

Citations

This map shows the geographic impact of Roya Zoraghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roya Zoraghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roya Zoraghi more than expected).

Fields of papers citing papers by Roya Zoraghi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roya Zoraghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roya Zoraghi. The network helps show where Roya Zoraghi may publish in the future.

Co-authorship network of co-authors of Roya Zoraghi

This figure shows the co-authorship network connecting the top 25 collaborators of Roya Zoraghi. A scholar is included among the top collaborators of Roya Zoraghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roya Zoraghi. Roya Zoraghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumar, Nag S., Edie Dullaghan, B. Brett Finlay, et al.. (2014). Discovery and optimization of a new class of pyruvate kinase inhibitors as potential therapeutics for the treatment of methicillin-resistant Staphylococcus aureus infections. Bioorganic & Medicinal Chemistry. 22(5). 1708–1725. 38 indexed citations

Zoraghi, Roya, Sara C. Campbell, Edie Dullaghan, et al.. (2014). Discovery of a 1,2-bis(3-indolyl)ethane that selectively inhibits the pyruvate kinase of methicillin-resistant Staphylococcus aureus over human isoforms. Bioorganic & Medicinal Chemistry Letters. 24(21). 5059–5062. 15 indexed citations

Veale, Clinton G. L., Kevin A. Lobb, Roya Zoraghi, et al.. (2014). Synthesis and MRSA PK inhibitory activity of thiazole containing deoxytopsentin analogues. Tetrahedron. 70(43). 7845–7853. 16 indexed citations

Zoraghi, Roya & Neil E. Reiner. (2013). Protein interaction networks as starting points to identify novel antimicrobial drug targets. Current Opinion in Microbiology. 16(5). 566–572. 36 indexed citations

Kumar, Nag S., Artem Cherkasov, B. Brett Finlay, et al.. (2012). Optimization and structure–activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents. Bioorganic & Medicinal Chemistry. 20(24). 7069–7082. 26 indexed citations

Zoraghi, Roya, L.J. Worrall, Raymond H. See, et al.. (2011). Methicillin-resistant Staphylococcus aureus (MRSA) Pyruvate Kinase as a Target for Bis-indole Alkaloids with Antibacterial Activities. Journal of Biological Chemistry. 286(52). 44716–44725. 109 indexed citations

Corbin, Jackie D., Roya Zoraghi, & Sharron H. Francis. (2009). Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme. Cellular Signalling. 21(12). 1768–1774. 19 indexed citations

Bessay, Emmanuel P., Mitsi A. Blount, Roya Zoraghi, et al.. (2008). Phosphorylation Increases Affinity of the Phosphodiesterase-5 Catalytic Site for Tadalafil. Journal of Pharmacology and Experimental Therapeutics. 325(1). 62–68. 16 indexed citations

Weeks, James L., Roya Zoraghi, Sharron H. Francis, & Jackie D. Corbin. (2007). N-Terminal Domain of Phosphodiesterase-11A4 (PDE11A4) Decreases Affinity of the Catalytic Site for Substrates and Tadalafil, and is Involved in Oligomerization. Biochemistry. 46(36). 10353–10364. 22 indexed citations

10.

Blount, Mitsi A., Roya Zoraghi, Emmanuel P. Bessay, et al.. (2007). Conversion of Phosphodiesterase-5 (PDE5) Catalytic Site to Higher Affinity by PDE5 Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 323(2). 730–737. 22 indexed citations

11.

Blount, Mitsi A., Roya Zoraghi, Hengming Ke, et al.. (2006). A 46-Amino Acid Segment in Phosphodiesterase-5 GAF-B Domain Provides for High Vardenafil Potency over Sildenafil and Tadalafil and Is Involved in Phosphodiesterase-5 Dimerization. Molecular Pharmacology. 70(5). 1822–1831. 30 indexed citations

12.

Wang, Huanchen, Yudong Liu, Qing Huai, et al.. (2006). Multiple Conformations of Phosphodiesterase-5. Journal of Biological Chemistry. 281(30). 21469–21479. 139 indexed citations

13.

Weeks, James L., Mitsi A. Blount, Alfreda Beasley, et al.. (2005). Radiolabeled Ligand Binding to the Catalytic or Allosteric Sites of PDE5 and PDE11. Humana Press eBooks. 307. 239–262. 10 indexed citations

14.

Zoraghi, Roya, Emmanuel P. Bessay, Jackie D. Corbin, & Sharron H. Francis. (2005). Structural and Functional Features in Human PDE5A1 Regulatory Domain That Provide for Allosteric cGMP Binding, Dimerization, and Regulation. Journal of Biological Chemistry. 280(12). 12051–12063. 84 indexed citations

15.

Corbin, Jackie D., Sharron H. Francis, & Roya Zoraghi. (2005). Tyrosine-612 in PDE5 contributes to higher affinity for vardenafil over sildenafil. International Journal of Impotence Research. 18(3). 251–257. 13 indexed citations

16.

Blount, Mitsi A., Alfreda Beasley, Roya Zoraghi, et al.. (2004). Binding of Tritiated Sildenafil, Tadalafil, or Vardenafil to the Phosphodiesterase-5 Catalytic Site Displays Potency, Specificity, Heterogeneity, and cGMP Stimulation. Molecular Pharmacology. 66(1). 144–152. 144 indexed citations

17.

Weeks, James L., Roya Zoraghi, Alfreda Beasley, et al.. (2004). High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients. International Journal of Impotence Research. 17(1). 5–9. 60 indexed citations

18.

Gong, KeWei, Stefan Kunz, Roya Zoraghi, et al.. (2001). cAMP-specific phosphodiesterase TbPDE1 is not essential in Trypanosoma brucei in culture or during midgut infection of tsetse flies. Molecular and Biochemical Parasitology. 116(2). 229–232. 13 indexed citations

19.

Zoraghi, Roya, et al.. (2001). Characterization of TbPDE2A, a Novel Cyclic Nucleotide-specific Phosphodiesterase from the Protozoan Parasite Trypanosoma brucei. Journal of Biological Chemistry. 276(15). 11559–11566. 27 indexed citations

20.

Seebeck, Thomas, et al.. (2001). cAMP signalling in Trypanosoma brucei. International Journal for Parasitology. 31(5-6). 491–498. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact